Stocks · News reference

8-K filing — Atara Biotherapeutics, Inc. (ATRA)

Aug 12, 2026, 8:10 PMSEC EDGAR

Filed: 2026-08-12 AccNo: 0001193125-26-346857 Size: 455 KB Item 2.02: Results of Operations and Financial Condition

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 12, 2026, 8:25 PMBenzinga Newsdesk
Atara Biotherapeutics Q2 EPS $(0.32), Inline, Sales $630.000K Beat $366.667K Estimate
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 268.42 percent decrease over earnings of $0.19 per share from the same period last
Read original at benzinga
ATRA